Literature DB >> 10395151

Perioperative antibiotic prophylaxis in Spanish hospitals: results of a questionnaire survey. Hospital Pharmacy Antimicrobial Prophylaxis Study Group.

C Codina1, A Trilla, N Riera, M Tuset, X Carne, J Ribas, M A Asenjo.   

Abstract

A questionnaire survey was sent to a random sample of the Spanish network of National Health System public acute-care hospitals. Of responding institutions (representing 25% of Spanish hospital beds), nearly 75% had active surveillance programs for the prevention and control of surgical-site infections (SSIs), but only 20% performed postdischarge surveillance. Overall, perioperative antibiotic prophylaxis (PAP) was used in 84% of all surgical procedures. For 77% of procedures, there were written guidelines for the choice and use of PAP. Cefazolin was the most commonly used antibiotic (38%). Duration of PAP was shorter than 24 hours in 75% of procedures, and only a single dose was given in 52% of procedures. PAP was commonly used in breast (52%) and inguinal hernia repair (69%) procedures, as well as in laparoscopic abdominal surgery (86%). In summary, the use of PAP in Spanish hospitals is adequate, but improvements can be made in the frequency of prolonged PAP and in the use of broad-spectrum antibiotics. Surveillance systems for SSI, including postdischarge follow-up, also should be improved.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395151     DOI: 10.1086/501650

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  Antibiotic prophylaxis for prevention of postoperative wound infection in adults undergoing open elective inguinal or femoral hernia repair.

Authors:  Claudia C Orelio; Coen van Hessen; Francisco Javier Sanchez-Manuel; Theodorus J Aufenacker; Rob Jpm Scholten
Journal:  Cochrane Database Syst Rev       Date:  2020-04-21

2.  Postoperative antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery: a retrospective cohort study.

Authors:  C-J Busch; R Knecht; A Münscher; J Matern; C Dalchow; B B Lörincz
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-18       Impact factor: 2.503

Review 3.  Antibiotic prophylaxis for hernia repair.

Authors:  Francisco Javier Sanchez-Manuel; Javier Lozano-García; Juan Luis Seco-Gil
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

4.  Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice.

Authors:  Sergio A Acuna; Fernando A Angarita; Jaime Escallon; Mauricio Tawil; Lilian Torregrosa
Journal:  BMC Surg       Date:  2012-08-31       Impact factor: 2.102

5.  Use of antibiotic prophylaxis in elective inguinal hernia repair in adults in London and south-east England: a cross-sectional survey.

Authors:  A M Aiken; J B Haddow; N R A Symons; S Kaptanis; A C Katz-Summercorn; D Debnath; H Dent; S Tayeh; V Kung; S Clark; J Gahir; S Dindyal; S Farag; A Lazaridis; C P Bretherton; S Williams; A Currie; H West; J Davies; S Arora; A Kheraj; B M Stubbs; N Yassin; S Mallappa; G Garrett; S Hislop; A Bhangu; Y Abbey; I Al-Shoek; U Ahmad; G Sharp; A Memarzadeh; A Patel; F Ali; H Kaderbhai; C H Knowles
Journal:  Hernia       Date:  2013-03-31       Impact factor: 4.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.